Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus

2010 ◽  
Vol 37 (11) ◽  
pp. 1132-1139 ◽  
Author(s):  
Dario Tomasini ◽  
Thomas Mentzel ◽  
Markus Hantschke ◽  
Amilcare Cerri ◽  
Bruno Paredes ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Lupus Erythematosus ◽  
Skin Diseases ◽  
Cutaneous Lupus Erythematosus ◽  
Plasmacytoid Dendritic Cells ◽  
Lymphocytic Infiltrate ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin ◽  
Cutaneous Lupus

scholarly journals Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases

2009 ◽  
Vol 29 (3) ◽  
pp. 247-256 ◽  
Author(s):  
Leanne M. Johnson-Huang ◽  
N. Scott McNutt ◽  
James G. Krueger ◽  
Michelle A. Lowes
Keyword(s):  
Dendritic Cells ◽  
Skin Diseases ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin

scholarly journals Expression and Function of the Mannose Receptor CD206 on Epidermal Dendritic Cells in Inflammatory Skin Diseases

2002 ◽  
Vol 118 (2) ◽  
pp. 327-334 ◽  
Author(s):  
Andreas Wollenberg ◽  
Tilmann Oppel ◽  
Eva-Maria Schottdorf ◽  
Sandra Günther ◽  
Martina Moderer ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Skin Diseases ◽  
Mannose Receptor ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin ◽  
And Function ◽  
Epidermal Dendritic Cells

scholarly journals Clinical outcome measures for cutaneous lupus erythematosus

Lupus ◽  
2010 ◽  
Vol 19 (9) ◽  
pp. 1137-1143 ◽  
Author(s):  
J. Albrecht ◽  
VP Werth
Keyword(s):  
Outcome Measures ◽  
Lupus Erythematosus ◽  
Skin Diseases ◽  
Cutaneous Lupus Erythematosus ◽  
Severity Index ◽  
Controlled Clinical Trials ◽  
Global Response ◽  
Organ Specific ◽  
Cutaneous Lupus

Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin diseases that only rarely have been subjected to controlled clinical trials. This may have been partly due to a lack of suitable validated outcome instruments. Recently, the Food and Drug Administration (FDA) mandated that organ-specific trials for lupus erythematosus need to use a combination of different outcome measures. The patient’s condition needs to be assessed in terms of quality of life, the patient’s global response, and organ-specific instruments that measure activity of the disease as well as damage due to the disease. For the skin, the only formally validated and published instrument is currently the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI). This paper discusses the background of the development of the CLASI as well as issues related to its use and interpretation in the context of clinical research of CLE. Lupus (2010) 19, 1137—1143.

scholarly journals Patchy Alopecia in a Patient with Rheumatoid Arthritis: A Practical Application of Trichoscopy

2021 ◽  
pp. 42-46
Author(s):  
Ahmad Vafaeian ◽  
Elham Taghizadeh ◽  
Maryam Daneshpazhooh ◽  
Hamidreza Mahmoudi
Keyword(s):  
Rheumatoid Arthritis ◽  
Lupus Erythematosus ◽  
Tinea Capitis ◽  
Skin Diseases ◽  
Cutaneous Lupus Erythematosus ◽  
Proper Treatment ◽  
Practical Application ◽  
History Of ◽  
Cutaneous Lupus

Trichoscopy is an efficient, convenient, and accurate diagnostic dermatological procedure which is widely used in the examination of patients with skin diseases. Herein, we report a 56-year-old woman with a long-term history of rheumatoid arthritis complaining of pruritic patchy alopecia on her scalp who was referred for biopsy to exclude cutaneous lupus erythematosus. Taking advantage of trichoscopy, we were able to quickly diagnose tinea capitis. Following administration of the proper treatment the disease resolved completely.

Sign in / Sign up

Export Citation Format

Share Document